Clinical Trial Update: Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders [NA]

View source ↗

Summary

This trial update reports on the completion of a study evaluating methylphenidate for children and adolescents with pervasive developmental disorders, including…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder
• Pervasive Developmental Disorders

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Attention Deficit Disorder With Hyperactivity, Autistic Disorder | NA | Status: COMPLETED